Gentel Biosciences | GenomeWeb

Gentel Biosciences

NEW YORK (GenomeWeb News) – Intuitive Biosciences today announced an agreement to purchase the animal health and research tools assets and businesses of Gentel Biosciences for an undisclosed amount.
The deal is expected to close during the second quarter.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Gentel Biosciences today announced a licensing deal with Oregon Health & Science University covering viral antigens for use on its Colony Surveillance Assays.

Gentel has acquired the SilverQuant trademark from Eppendorf, which it will apply to its protein array technology platform.

The patent covers a "high-throughput method of screening for a biomarker indicative of a disease" and includes "methods utilizing a microarray to measure the glycan level of a protein."

New Product Watch

Premium

Agilent Technologies' SurePrint G3 Human CGH+SNP Microarray, Gentel Biosciences' APiX Simian Pathogen Array

The companies are developing kits that combine Gentel's APiX technology and RayBiotech's collection of more than 55 antibody and protein arrays on a glass slide format.

New Products

Premium

BAC, Gentel Biosciences, Phoenix S&T, Waters

Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.

New Product Watch

Premium

Gentel Biosciences' APiX Disease Profiling Kit, Randox Laboratories' Metabolic Syndrome Arrays

New Products

Premium

Gentel Biosciences, GE Healthcare

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.